Angiogenesis inhibitors in diabetic macular edema

    Abstract

    Angiogenesis inhibitors in diabetic macular edema

    Botabekova T.K., Otarova Zh.K., Stepanova I.S., Odintsov K.V., Kaliyeva A.T., Musayeva Z.M.

    Kazakh Research Institute of Eye Diseases, Almaty (Kazakhstan)

    

    One of the main reasons for the decline of diabetic retinopathy is a diabetic maculopathy (DM), including one of its main manifestations – diabetic macular edema (DME). Studies of results of anti-VEGF therapy and its use at the forefront in the fight against DHS. The article shows the results of angiogenesis inhibitors in DME.

    Key words: diabetic retinopathy, diabetic macular edema, anti-VEGF therapy, intravitreal injection.